Retrovirology最新文献

筛选
英文 中文
Impact of HIV-1 CRF55_01B infection on the evolution of CD4 count and plasma HIV RNA load in men who have sex with men prior to antiretroviral therapy. HIV-1 CRF55_01B感染对抗逆转录病毒治疗前男男性行为者CD4计数和血浆HIV RNA载量演变的影响
IF 3.3 3区 医学
Retrovirology Pub Date : 2021-08-16 DOI: 10.1186/s12977-021-00567-z
Lan Wei, Hao Li, Xing Lv, Chenli Zheng, Guilian Li, Zhengrong Yang, Lin Chen, Xiaoxu Han, Huachun Zou, Yanxiao Gao, Jinquan Cheng, Hui Wang, Jin Zhao
{"title":"Impact of HIV-1 CRF55_01B infection on the evolution of CD4 count and plasma HIV RNA load in men who have sex with men prior to antiretroviral therapy.","authors":"Lan Wei,&nbsp;Hao Li,&nbsp;Xing Lv,&nbsp;Chenli Zheng,&nbsp;Guilian Li,&nbsp;Zhengrong Yang,&nbsp;Lin Chen,&nbsp;Xiaoxu Han,&nbsp;Huachun Zou,&nbsp;Yanxiao Gao,&nbsp;Jinquan Cheng,&nbsp;Hui Wang,&nbsp;Jin Zhao","doi":"10.1186/s12977-021-00567-z","DOIUrl":"https://doi.org/10.1186/s12977-021-00567-z","url":null,"abstract":"<p><strong>Background: </strong>CRF55_01B is a newly identified HIV-1 circulating recombinant form originated from MSM in China. However, its impact on the disease progression and transmission risk has not been investigated. This study aimed to determine the impact of CRF55_01B infection on viral dynamics and immunological status so as to provide scientific evidence for further control and prevention effort on CRF55_01B. Linear mixed effect models were applied to evaluate CD4 cell count decline and viral load increase by subtype.</p><p><strong>Results: </strong>Of the 3418 blood samples, 1446 (42.3%) were CRF07_BC, 1169 (34.2%) CRF01_AE, 467 (13.7%) CRF55_01B, 249 (7.3%) type B, and 87 (2.5%) other subtypes (CRF_08BC, CRF_01B, C). CRF55_01B had become the third predominant strain since 2012 in Shenzhen, China. CRF55_01B-infected MSM showed lower median of CD4 count than CRF07_BC-infected MSM (349.5 [IQR, 250.2-474.8] vs. 370.0 [IQR, 278.0-501.0], P < 0.05). CRF55_01B infection was associated with slower loss of CD4 count than CRF01_AE (13.6 vs. 23.3 [cells/µl]¹/²/year, P < 0.05)among MSM with initial CD4 count of 200-350 cells/µl. On the other hand, those infected with CRF55_01B showed higher median plasma HIV RNA load (5.4 [IQR, 5.0-5.9]) than both CRF01_AE (5.3 [IQR, 4.8-5.7], P < 0.05) and CRF07_BC (5.0 log10 [IQR, 4.5-5.5], P < 0.001) at the initiation of antiretroviral therapy. Furthermore, the annual increasing rate of viral load for CRF55_01B infection was significantly higher than that of CRF07_BC (2.0 vs. 0.7 log10 copies/ml/year, P < 0.01).</p><p><strong>Conclusions: </strong>The relatively lower CD4 count and faster increase of plasma HIV RNA load of CRF55_01B-infected MSM without antiretroviral therapy suggest that CRF55_01B may lead to longer asymptomatic phase and higher risk of HIV transmission. Strengthened surveillance, tailored prevention strategies and interventions, and in-depth research focusing on CRF55_01B are urgently needed to forestall potential epidemic.</p>","PeriodicalId":21123,"journal":{"name":"Retrovirology","volume":" ","pages":"22"},"PeriodicalIF":3.3,"publicationDate":"2021-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8365277/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39318679","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
HIV-1 capsid exploitation of the host microtubule cytoskeleton during early infection. 早期感染期间宿主微管细胞骨架的HIV-1衣壳开发。
IF 3.3 3区 医学
Retrovirology Pub Date : 2021-07-06 DOI: 10.1186/s12977-021-00563-3
Mojgan H Naghavi
{"title":"HIV-1 capsid exploitation of the host microtubule cytoskeleton during early infection.","authors":"Mojgan H Naghavi","doi":"10.1186/s12977-021-00563-3","DOIUrl":"https://doi.org/10.1186/s12977-021-00563-3","url":null,"abstract":"<p><p>Microtubules (MTs) form a filamentous array that provide both structural support and a coordinated system for the movement and organization of macromolecular cargos within the cell. As such, they play a critical role in regulating a wide range of cellular processes, from cell shape and motility to cell polarization and division. The array is radial with filament minus-ends anchored at perinuclear MT-organizing centers and filament plus-ends continuously growing and shrinking to explore and adapt to the intracellular environment. In response to environmental cues, a small subset of these highly dynamic MTs can become stabilized, acquire post-translational modifications and act as specialized tracks for cargo trafficking. MT dynamics and stability are regulated by a subset of highly specialized MT plus-end tracking proteins, known as +TIPs. Central to this is the end-binding (EB) family of proteins which specifically recognize and track growing MT plus-ends to both regulate MT polymerization directly and to mediate the accumulation of a diverse array of other +TIPs at MT ends. Moreover, interaction of EB1 and +TIPs with actin-MT cross-linking factors coordinate changes in actin and MT dynamics at the cell periphery, as well as during the transition of cargos from one network to the other. The inherent structural polarity of MTs is sensed by specialized motor proteins. In general, dynein directs trafficking of cargos towards the minus-end while most kinesins direct movement toward the plus-end. As a pathogenic cargo, HIV-1 uses the actin cytoskeleton for short-range transport most frequently at the cell periphery during entry before transiting to MTs for long-range transport to reach the nucleus. While the fundamental importance of MT networks to HIV-1 replication has long been known, recent work has begun to reveal the underlying mechanistic details by which HIV-1 engages MTs after entry into the cell. This includes mimicry of EB1 by capsid (CA) and adaptor-mediated engagement of dynein and kinesin motors to elegantly coordinate early steps in infection that include MT stabilization, uncoating (conical CA disassembly) and virus transport toward the nucleus. This review discusses recent advances in our understanding of how MT regulators and their associated motors are exploited by incoming HIV-1 capsid during early stages of infection.</p>","PeriodicalId":21123,"journal":{"name":"Retrovirology","volume":" ","pages":"19"},"PeriodicalIF":3.3,"publicationDate":"2021-07-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s12977-021-00563-3","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39158685","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 17
Interview with a Retrovirologist: Sebla B. Kutluay in conversation with Carol Carter. 采访逆转录病毒学家:Sebla B. Kutluay与Carol Carter的谈话。
IF 3.3 3区 医学
Retrovirology Pub Date : 2021-07-01 DOI: 10.1186/s12977-021-00562-4
Carol Carter, Sebla B Kutluay
{"title":"Interview with a Retrovirologist: Sebla B. Kutluay in conversation with Carol Carter.","authors":"Carol Carter,&nbsp;Sebla B Kutluay","doi":"10.1186/s12977-021-00562-4","DOIUrl":"https://doi.org/10.1186/s12977-021-00562-4","url":null,"abstract":"","PeriodicalId":21123,"journal":{"name":"Retrovirology","volume":" ","pages":"18"},"PeriodicalIF":3.3,"publicationDate":"2021-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s12977-021-00562-4","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39153091","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Heterologous avian system for quantitative analysis of Syncytin-1 interaction with ASCT2 receptor. 异种禽类系统中Syncytin-1与ASCT2受体相互作用的定量分析。
IF 3.3 3区 医学
Retrovirology Pub Date : 2021-06-22 DOI: 10.1186/s12977-021-00558-0
Kryštof Štafl, Martin Trávníček, Dana Kučerová, Ľubomíra Pecnová, Veronika Krchlíková, Eliška Gáliková, Volodymyr Stepanets, Jiří Hejnar, Kateřina Trejbalová
{"title":"Heterologous avian system for quantitative analysis of Syncytin-1 interaction with ASCT2 receptor.","authors":"Kryštof Štafl,&nbsp;Martin Trávníček,&nbsp;Dana Kučerová,&nbsp;Ľubomíra Pecnová,&nbsp;Veronika Krchlíková,&nbsp;Eliška Gáliková,&nbsp;Volodymyr Stepanets,&nbsp;Jiří Hejnar,&nbsp;Kateřina Trejbalová","doi":"10.1186/s12977-021-00558-0","DOIUrl":"https://doi.org/10.1186/s12977-021-00558-0","url":null,"abstract":"<p><strong>Background: </strong>Human Syncytin-1 is a placentally-expressed cell surface glycoprotein of retroviral origin. After interaction with ASCT2, its cellular receptor, Syncytin-1 triggers cell-cell fusion and formation of a multinuclear syncytiotrophoblast layer of the placenta. The ASCT2 receptor is a multi-spanning membrane protein containing a protruding extracellular part called region C, which has been suggested to be a retrovirus docking site. Precise identification of the interaction site between ASCT2 and Syncytin-1 is challenging due to the complex structure of ASCT2 protein and the background of endogenous ASCT2 gene in the mammalian genome. Chicken cells lack the endogenous background and, therefore, can be used to set up a system with surrogate expression of the ASCT2 receptor.</p><p><strong>Results: </strong>We have established a retroviral heterologous chicken system for rapid and reliable assessment of ectopic human ASCT2 protein expression. Our dual-fluorescence system proved successful for large-scale screening of mutant ASCT2 proteins. Using this system, we demonstrated that progressive deletion of region C substantially decreased the amount of ASCT2 protein. In addition, we implemented quantitative assays to determine the interaction of ASCT2 with Syncytin-1 at multiple levels, which included binding of the soluble form of Syncytin-1 to ASCT2 on the cell surface and a luciferase-based assay to evaluate cell-cell fusions that were triggered by Syncytin-1. Finally, we restored the envelope function of Syncytin-1 in a replication-competent retrovirus and assessed the infection of chicken cells expressing human ASCT2 by chimeric Syncytin-1-enveloped virus. The results of the quantitative assays showed that deletion of the protruding region C did not abolish the interaction of ASCT2 with Syncytin-1.</p><p><strong>Conclusions: </strong>We present here a heterologous chicken system for effective assessment of the expression of transmembrane ASCT2 protein and its interaction with Syncytin-1. The system profits from the absence of endogenous ASCT2 background and implements the quantitative assays to determine the ASCT2-Syncytin-1 interaction at several levels. Using this system, we demonstrated that the protruding region C was essential for ASCT2 protein expression, but surprisingly, not for the interaction with Syncytin-1 glycoprotein.</p>","PeriodicalId":21123,"journal":{"name":"Retrovirology","volume":" ","pages":"15"},"PeriodicalIF":3.3,"publicationDate":"2021-06-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s12977-021-00558-0","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39029037","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Humanized Mice for Infectious and Neurodegenerative disorders. 用于感染性和神经退行性疾病的人源化小鼠。
IF 2.7 3区 医学
Retrovirology Pub Date : 2021-06-05 DOI: 10.1186/s12977-021-00557-1
Prasanta K Dash, Santhi Gorantla, Larisa Poluektova, Mahmudul Hasan, Emiko Waight, Chen Zhang, Milica Markovic, Benson Edagwa, Jatin Machhi, Katherine E Olson, Xinglong Wang, R Lee Mosley, Bhavesh Kevadiya, Howard E Gendelman
{"title":"Humanized Mice for Infectious and Neurodegenerative disorders.","authors":"Prasanta K Dash, Santhi Gorantla, Larisa Poluektova, Mahmudul Hasan, Emiko Waight, Chen Zhang, Milica Markovic, Benson Edagwa, Jatin Machhi, Katherine E Olson, Xinglong Wang, R Lee Mosley, Bhavesh Kevadiya, Howard E Gendelman","doi":"10.1186/s12977-021-00557-1","DOIUrl":"10.1186/s12977-021-00557-1","url":null,"abstract":"<p><p>Humanized mice model human disease and as such are used commonly for research studies of infectious, degenerative and cancer disorders. Recent models also reflect hematopoiesis, natural immunity, neurobiology, and molecular pathways that influence disease pathobiology. A spectrum of immunodeficient mouse strains permit long-lived human progenitor cell engraftments. The presence of both innate and adaptive immunity enables high levels of human hematolymphoid reconstitution with cell susceptibility to a broad range of microbial infections. These mice also facilitate investigations of human pathobiology, natural disease processes and therapeutic efficacy in a broad spectrum of human disorders. However, a bridge between humans and mice requires a complete understanding of pathogen dose, co-morbidities, disease progression, environment, and genetics which can be mirrored in these mice. These must be considered for understanding of microbial susceptibility, prevention, and disease progression. With known common limitations for access to human tissues, evaluation of metabolic and physiological changes and limitations in large animal numbers, studies in mice prove important in planning human clinical trials. To these ends, this review serves to outline how humanized mice can be used in viral and pharmacologic research emphasizing both current and future studies of viral and neurodegenerative diseases. In all, humanized mouse provides cost-effective, high throughput studies of infection or degeneration in natural pathogen host cells, and the ability to test transmission and eradication of disease.</p>","PeriodicalId":21123,"journal":{"name":"Retrovirology","volume":"18 1","pages":"13"},"PeriodicalIF":2.7,"publicationDate":"2021-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8179712/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9762126","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A single G10T polymorphism in HIV-1 subtype C Gag-SP1 regulates sensitivity to maturation inhibitors. HIV-1 C亚型Gag-SP1中单个G10T多态性调节对成熟抑制剂的敏感性。
IF 3.3 3区 医学
Retrovirology Pub Date : 2021-04-09 DOI: 10.1186/s12977-021-00553-5
Dibya Ghimire, Yuvraj Kc, Uddhav Timilsina, Kriti Goel, T J Nitz, Carl T Wild, Ritu Gaur
{"title":"A single G10T polymorphism in HIV-1 subtype C Gag-SP1 regulates sensitivity to maturation inhibitors.","authors":"Dibya Ghimire,&nbsp;Yuvraj Kc,&nbsp;Uddhav Timilsina,&nbsp;Kriti Goel,&nbsp;T J Nitz,&nbsp;Carl T Wild,&nbsp;Ritu Gaur","doi":"10.1186/s12977-021-00553-5","DOIUrl":"https://doi.org/10.1186/s12977-021-00553-5","url":null,"abstract":"<p><strong>Background: </strong>Maturation inhibitors (MIs) potently block HIV-1 maturation by inhibiting the cleavage of the capsid protein and spacer peptide 1 (CA-SP1). Bevirimat (BVM), a highly efficacious first-in-class MI against HIV-1 subtype B isolates, elicited sub-optimal efficacy in clinical trials due to polymorphisms in the CA-SP1 region of the Gag protein (SP1:V7A). HIV-1 subtype C inherently contains this polymorphism thus conferring BVM resistance, however it displayed sensitivity to second generation BVM analogs.</p><p><strong>Results: </strong>In this study, we have assessed the efficacy of three novel second-generation MIs (BVM analogs: CV-8611, CV-8612, CV-8613) against HIV-1 subtype B and C isolates. The BVM analogs were potent inhibitors of both HIV-1 subtype B (NL4-3) and subtype C (K3016) viruses. Serial passaging of the subtype C, K3016 virus strain in the presence of BVM analogs led to identification of two mutant viruses-Gag SP1:A1V and CA:I201V. While the SP1:A1V mutant was resistant to the MIs, the CA:I120V mutant displayed partial resistance and a MI-dependent phenotype. Further analysis of the activity of the BVM analogs against two additional HIV-1 subtype C strains, IndieC1 and ZM247 revealed that they had reduced sensitivity as compared to K3016. Sequence analysis of the three viruses identified two polymorphisms at SP1 residues 9 and 10 (K3016: N9, G10; IndieC1/ZM247: S9, T10). The N9S and S9N mutants had no change in MI-sensitivity. On the other hand, replacing glycine at residue 10 with threonine in K3016 reduced its MI sensitivity whereas introducing glycine at SP1 10 in place of threonine in IndieC1 and ZM247 significantly enhanced their MI sensitivity. Thus, the specific glycine residue 10 of SP1 in the HIV-1 subtype C viruses determined sensitivity towards BVM analogs.</p><p><strong>Conclusions: </strong>We have identified an association of a specific glycine at position 10 of Gag-SP1 with an MI susceptible phenotype of HIV-1 subtype C viruses. Our findings have highlighted that HIV-1 subtype C viruses, which were inherently resistant to BVM, may also be similarly predisposed to exhibit a significant degree of resistance to second-generation BVM analogs. Our work has strongly suggested that genetic differences between HIV-1 subtypes may produce variable MI sensitivity that needs to be considered in the development of novel, potent, broadly-active MIs.</p>","PeriodicalId":21123,"journal":{"name":"Retrovirology","volume":" ","pages":"9"},"PeriodicalIF":3.3,"publicationDate":"2021-04-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8033686/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25577223","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Memoriam for Renaud Mahieux. 为Renaud Mahieux纪念。
IF 3.3 3区 医学
Retrovirology Pub Date : 2021-03-17 DOI: 10.1186/s12977-021-00551-7
Fatah Kashanchi, Ali Bazarbachi, Antoine Gessain
{"title":"Memoriam for Renaud Mahieux.","authors":"Fatah Kashanchi,&nbsp;Ali Bazarbachi,&nbsp;Antoine Gessain","doi":"10.1186/s12977-021-00551-7","DOIUrl":"https://doi.org/10.1186/s12977-021-00551-7","url":null,"abstract":"","PeriodicalId":21123,"journal":{"name":"Retrovirology","volume":" ","pages":"7"},"PeriodicalIF":3.3,"publicationDate":"2021-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s12977-021-00551-7","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25488158","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Elevated levels of inflammatory plasma biomarkers are associated with risk of HIV infection. 炎症血浆生物标志物水平升高与HIV感染风险相关。
IF 3.3 3区 医学
Retrovirology Pub Date : 2021-03-17 DOI: 10.1186/s12977-021-00552-6
Samantha McInally, Kristin Wall, Tianwei Yu, Rabindra Tirouvanziam, William Kilembe, Jill Gilmour, Susan A Allen, Eric Hunter
{"title":"Elevated levels of inflammatory plasma biomarkers are associated with risk of HIV infection.","authors":"Samantha McInally,&nbsp;Kristin Wall,&nbsp;Tianwei Yu,&nbsp;Rabindra Tirouvanziam,&nbsp;William Kilembe,&nbsp;Jill Gilmour,&nbsp;Susan A Allen,&nbsp;Eric Hunter","doi":"10.1186/s12977-021-00552-6","DOIUrl":"https://doi.org/10.1186/s12977-021-00552-6","url":null,"abstract":"<p><strong>Background: </strong>To determine if individuals, from HIV-1 serodiscordant couple cohorts from Rwanda and Zambia, who become HIV-positive have a distinct inflammatory biomarker profile compared to individuals who remain HIV-negative, we compared levels of biomarkers in plasma of HIV-negative individuals who either seroconverted (pre-infection) and became HIV-positive or remained HIV-negative (uninfected).</p><p><strong>Results: </strong>We observed that individuals in the combined cohort, as well as those in the individual country cohorts, who later became HIV-1 infected had significantly higher baseline levels of multiple inflammatory cytokines/chemokines compared to individuals who remained HIV-negative. Genital inflammation/ulceration or schistosome infections were not associated with this elevated profile. Defined levels of ITAC and IL-7 were significant predictors of later HIV acquisition in ROC predictive analyses, whereas the classical Th1 and Th2 inflammatory cytokines such as IL-12 and interferon-γ or IL-4, IL-5 and Il-13 were not.</p><p><strong>Conclusions: </strong>Overall, the data show a significant association between increased plasma biomarkers linked to inflammation and immune activation and HIV acquisition and suggests that pre-existing conditions that increase systemic biomarkers represent a factor for increased risk of HIV infection.</p>","PeriodicalId":21123,"journal":{"name":"Retrovirology","volume":" ","pages":"8"},"PeriodicalIF":3.3,"publicationDate":"2021-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s12977-021-00552-6","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25487873","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Correction to: Human T-cell leukaemia virus type 1 associated pulmonary disease: clinical and pathological features of an under-recognised complication of HTLV-1 infection. 更正:人类t细胞白血病病毒1型相关肺部疾病:HTLV-1感染未被认识的并发症的临床和病理特征
IF 3.3 3区 医学
Retrovirology Pub Date : 2021-02-22 DOI: 10.1186/s12977-021-00549-1
Lloyd Einsiedel, Fabian Chiong, Hubertus Jersmann, Graham P Taylor
{"title":"Correction to: Human T-cell leukaemia virus type 1 associated pulmonary disease: clinical and pathological features of an under-recognised complication of HTLV-1 infection.","authors":"Lloyd Einsiedel,&nbsp;Fabian Chiong,&nbsp;Hubertus Jersmann,&nbsp;Graham P Taylor","doi":"10.1186/s12977-021-00549-1","DOIUrl":"https://doi.org/10.1186/s12977-021-00549-1","url":null,"abstract":"","PeriodicalId":21123,"journal":{"name":"Retrovirology","volume":" ","pages":"5"},"PeriodicalIF":3.3,"publicationDate":"2021-02-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s12977-021-00549-1","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25400027","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Vpx enhances innate immune responses independently of SAMHD1 during HIV-1 infection. Vpx在HIV-1感染期间独立于SAMHD1增强先天免疫应答。
IF 3.3 3区 医学
Retrovirology Pub Date : 2021-02-09 DOI: 10.1186/s12977-021-00548-2
Oya Cingöz, Nicolas D Arnow, Mireia Puig Torrents, Norbert Bannert
{"title":"Vpx enhances innate immune responses independently of SAMHD1 during HIV-1 infection.","authors":"Oya Cingöz,&nbsp;Nicolas D Arnow,&nbsp;Mireia Puig Torrents,&nbsp;Norbert Bannert","doi":"10.1186/s12977-021-00548-2","DOIUrl":"https://doi.org/10.1186/s12977-021-00548-2","url":null,"abstract":"<p><strong>Background: </strong>The genomes of HIV-2 and some SIV strains contain the accessory gene vpx, which carries out several functions during infection, including the downregulation of SAMHD1. Vpx is also commonly used in experiments to increase HIV-1 infection efficiency in myeloid cells, particularly in studies that investigate the activation of antiviral pathways. However, the potential effects of Vpx on cellular innate immune signaling is not completely understood. We investigated whether and how Vpx affects ISG responses in monocytic cell lines and MDMs during HIV-1 infection.</p><p><strong>Results: </strong>HIV-1 infection at excessively high virus doses can induce ISG activation, although at the expense of high levels of cell death. At equal infection levels, the ISG response is potentiated by the presence of Vpx and requires the initiation of reverse transcription. The interaction of Vpx with the DCAF1 adaptor protein is important for the enhanced response, implicating Vpx-mediated degradation of a host factor. Cells lacking SAMHD1 show similarly augmented responses, suggesting an effect that is independent of SAMHD1 degradation. Overcoming SAMHD1 restriction in MDMs to reach equal infection levels with viruses containing and lacking Vpx reveals a novel function of Vpx in elevating innate immune responses.</p><p><strong>Conclusions: </strong>Vpx likely has as yet undefined roles in infected cells. Our results demonstrate that Vpx enhances ISG responses in myeloid cell lines and primary cells independently of its ability to degrade SAMHD1. These findings have implications for innate immunity studies in myeloid cells that use Vpx delivery with HIV-1 infection.</p>","PeriodicalId":21123,"journal":{"name":"Retrovirology","volume":" ","pages":"4"},"PeriodicalIF":3.3,"publicationDate":"2021-02-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s12977-021-00548-2","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25350377","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信